Search
for
Sort by
Research 241–270 of 1000+
- DEVELOPMENT AND VALIDATION OF A RP - HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE IN PURE AND PHARMACEUTICAL DOSAGE FORM
- Liquid chromatography-mass spectrometry for simultaneous determination of spironolactone and canrenone in plasma samples
- Assessment of the efficacy of topical antiandrogen; spironolactone in patients with androgenetic alopecia by dermoscopy
- Therapeutic Efficacy of Spironolactone for Central Serous Chorioretinopathy
- Spironolactone in Dermatology: A Mini Review
- Spironolactone and breast cancer: Fear not!
- FASCE, the benefit of spironolactone for treating acne in adult females: study protocol for a randomized double-blind trial
- FASCE, benefit of spironolactone for treating acne of adult female: study protocol for a randomized double-blind trial
- Spironolactone use and the risk of breast cancer
- Spironolactone
- Experimental study on the effects of spironolactone on human hair follicles in vitro
- USE OF SPIRONOLACTONE IN COMBINATION WITH AN ORAL CONTRACEPTIVE IN TREATMENT OF HIRSUTISM
- Preparation and clinical assessment of spironolactone-containing cream on hair growth in hirsute women
- Spironolactone treatment of porphyria cutanea tarda-associated hirsutism
- Spironolactone is an effective and well tolerated systemic anti-androgen therapy for hirsute women
- Spironolactone in the treatment of hirsutism.
- Spironolactone Reduces Facial and Body Hair in Women with Hirsutism
- SPIRONOLACTONE CUTS HAIR GROWTH IN IDIOPATHIC HIRSUTISM
- Exploring the historical stigma of spironolactone use in breast cancer survivors with alopecia
- 503 Use of low-dose spironolactone in female pattern hair loss in a specialty alopecia clinic
- Do Pleiotropic Effects of Spironolactone in Women with PCOS make it More Than an Anti-Androgen? Evidence from a Systematic Review and Meta-Analysis
- The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review
- Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia, comparative study.
- Retrospective analysis of the risk of hyperkalaemia in women older than 65 years of age prescribed spironolactone for female-pattern hair loss
- 33813 Retrospective study of the prevalence of hyperkalemia in women taking spironolactone for acne, hair loss, and hirsutism
- 33813 Retrospective study of the prevalence of hyperkalemia in women taking spironolactone for acne, hair loss, and hirsutism
- 33244 Increased risk of hyperkalemia in older women taking spironolactone for female pattern hair loss
- 451 Spironolactone for treatment of concomitant female pattern hair loss in scarring alopecia patients
- Topical Finasteride versus Topical Spironolactone in the Treatment of Androgenetic Alopecia
- A randomised trial of 5% minoxidil versus combination of 5% minoxidil and oral spironolactone in treatment of female pattern hair loss